CNST - Constellation Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development48,76932,61727,881
Selling General and Administrative12,4756,4715,777
Non Recurring---
Others---
Total Operating Expenses61,24439,08833,658
Operating Income or Loss-61,244-39,088-33,658
Income from Continuing Operations
Total Other Income/Expenses Net1,3193,711-875
Earnings Before Interest and Taxes-61,244-39,088-33,658
Interest Expense-228-901-1,345
Income Before Tax-59,925-35,377-34,533
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-59,925-35,377-34,533
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-59,925-35,377-34,533
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-59,925-53,767-49,465